CRSP

CRISPR THERAPEUTICS AG

Healthcare | Mid Cap

-$1.24

EPS Forecast

$5.55

Revenue Forecast

Announcing earnings for the quarter ending 2025-09-30 soon
REPLReplimune Group IncTECHBio-techne CorpNVAXNovavax IncDNLIDenali Therapeutics IncHALOHalozyme Therapeutics IncIOVAIovance Biotherapeutics IncNBIXNeurocrine Biosciences IncRGENRepligen CorpMRNAModerna Inc